EU go-ahead for paediatric anti-fungal
The European Medicines Agency's paediatric committee last week gave the go-ahead for a paediatric version of Merck Sharp and Dohme's Cancidas, for use in fungal infections - which like the adult version contains the echinocandin, caspofungin acetate, and now only needs to be authorised for marketing by the European Commission. This should happen within two months or so. The product is
0 Response to "EU go-ahead for paediatric anti-fungal"
Post a Comment